Rocket Pharmaceuticals is trading now at $3.94, up 5.76%, with no clear company-specific catalyst identified.

  • Live-market data is for September 2, 2026; no clear company-specific announcement, filing, earnings update, or analyst action was identified that day.
  • Latest prominent disclosures were August 10 second-quarter results and August 3 clinical safety update; neither explicitly explains the intraday move.
  • Broader markets were mixed, so macro sentiment does not clearly account for the gain.